Research Article
Is It Possible to Differentiate Chronic Kidney Disease and Preeclampsia by means of New and Old Biomarkers? A Prospective Study
Table 3
Molecular and biophysical biomarkers.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
: CKD versus PE versus Other; : CKD versus PE; : CKD versus Other; : PE versus Other. Note. Comparisons between groups: sFlt-1: ; ; . PlGF: ; ; . Ratio sFlt1-PlGF: ; ; ; prevalence of normal flows: ; ; . Presence of at least one impaired uteroplacental flow for diagnosis of PE and Other diseases versus CKD: sensitivity 56.1% (95% CI: 39.7%–71.5%); specificity 85.7% (95% CI: 69.7%–95.2%); PPV 82.1% (95% CI: 63.1%–93.9%); NPV value 62.5% (95% CI: 47.4%–76.0%). PE only versus CKD: sensitivity 62.5% (95% CI: 40.6%–81.2%); specificity 85.7% (95% CI: 69.7%–95.2%); PPV 75% (95% CI: 50.9%–91.3%); NPV: 76.9% (95% CI: 60.7%–88.9%). |